Hashimoto's patients in perimenopause Perimenopause adds another layer of complexity
That is one reason GLP-1 and GIP medications have become part of the conversation for some patients: by helping reduce appetite, improve blood sugar control, and support meaningful weight loss, they may offer an added tool for people whose thyroid treatment alone has not solved the weight struggle
Common GLP-1 side effects include nausea, vomiting, diarrhea, constipation, and injection-site reactions

Specific nutrients and compounds that have been studied for potential metabolic effects include: Omega-3 fatty acids from fish oil, which may have metabolic benefits, though evidence specifically for GLP-1 enhancement is limited Berberine , a plant alkaloid that has shown modest glucose-lowering effects in some small studies, though it may interact with certain medications through CYP enzymes and P-glycoprotein and should be avoided during pregnancy and lactation Curcumin from turmeric, which has been studied for various metabolic effects, though it may interact with anticoagulants and has limited bioavailability Green tea catechins , particularly epigallocatechin gallate (EGCG), though concentrated extracts have been associated with rare cases of liver injury It is important to note that the American Diabetes Association and American College of Physicians do not recommend routine use of dietary supplements for glycemic control due to limited evidence and potential safety concerns

Despite the FDAs assertion that injectable semaglutide supply has stabilized, some industry groups and healthcare providers remain skeptical
It works by helping you take control of appetite and cravings, while addressing the metabolic factors that often stand in the way of lasting results